Mdma molecule:

Image from PubChem

Mdma Clinical Trials

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

To see complete record on, please visit this link

Id: NCT05584826

Organisation Name: Sunstone Medical

Overal Status: Recruiting

Start Date: October 6, 2022

Last Update: October 18, 2022

Lead Sponsor: Sunstone Medical

Brief Summary: The goal of this clinical trial is to assess feasibility, tolerability and preliminary effectiveness of MDMA-assisted therapy for adjustment disorder (AD) in 10 dyads of patients with cancer and a concerned significant other (CSO) (20 participants total).

Participants will undergo an 8-week treatment period which will include two doses of MDMA, two Preparatory Sessions and four Integrative Sessions of non-drug therapy.

  • Cancer
  • Adjustment Disorders

Total execution time in seconds: 0.28544402122498